These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36115548)
1. LysM-positive neurons drive Tuberous Sclerosis Complex (TSC)-associated brain lesions. Zhang J; Xu S; Liang K; Cao X; Ye Z; Huang W; Bai X; Zhang Y Cell Signal; 2022 Dec; 100():110468. PubMed ID: 36115548 [TBL] [Abstract][Full Text] [Related]
2. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits. Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365 [TBL] [Abstract][Full Text] [Related]
3. Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice. Koike-Kumagai M; Fujimoto M; Wataya-Kaneda M Neuropharmacology; 2022 Nov; 218():109203. PubMed ID: 35931213 [TBL] [Abstract][Full Text] [Related]
4. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex. Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598 [TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of murine Tsc1-deficient neural stem progenitor cells. Chiaradia E; Miller I; Renzone G; Tognoloni A; Polchi A; De Marco F; Tancini B; Scaloni A; Magini A J Proteomics; 2023 Jul; 283-284():104928. PubMed ID: 37207814 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported. Niida Y; Wakisaka A; Tsuji T; Yamada H; Kuroda M; Mitani Y; Okumura A; Yokoi A J Hum Genet; 2013 Apr; 58(4):216-25. PubMed ID: 23389244 [TBL] [Abstract][Full Text] [Related]
9. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Way SW; McKenna J; Mietzsch U; Reith RM; Wu HC; Gambello MJ Hum Mol Genet; 2009 Apr; 18(7):1252-65. PubMed ID: 19150975 [TBL] [Abstract][Full Text] [Related]
10. A novel mouse model of tuberous sclerosis complex (TSC): eye-specific Tsc1-ablation disrupts visual-pathway development. Jones I; Hägglund AC; Törnqvist G; Nord C; Ahlgren U; Carlsson L Dis Model Mech; 2015 Dec; 8(12):1517-29. PubMed ID: 26449264 [TBL] [Abstract][Full Text] [Related]
11. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Carson RP; Van Nielen DL; Winzenburger PA; Ess KC Neurobiol Dis; 2012 Jan; 45(1):369-80. PubMed ID: 21907282 [TBL] [Abstract][Full Text] [Related]
12. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481 [TBL] [Abstract][Full Text] [Related]
13. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901 [TBL] [Abstract][Full Text] [Related]
14. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687 [TBL] [Abstract][Full Text] [Related]
15. A mouse model of craniofacial bone lesion of tuberous sclerosis complex. Fang F; Wei X; Hu M; Liu F Musculoskelet Regen; 2015; 1(1):. PubMed ID: 26052552 [TBL] [Abstract][Full Text] [Related]
16. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123). Crowell B; Lee GH; Nikolaeva I; Dal Pozzo V; D'Arcangelo G eNeuro; 2015; 2(6):. PubMed ID: 26693177 [TBL] [Abstract][Full Text] [Related]
17. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations. Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M; Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042 [TBL] [Abstract][Full Text] [Related]
18. The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth. Schrötter S; Yuskaitis CJ; MacArthur MR; Mitchell SJ; Hosios AM; Osipovich M; Torrence ME; Mitchell JR; Hoxhaj G; Sahin M; Manning BD Cell Rep; 2022 May; 39(7):110824. PubMed ID: 35584673 [TBL] [Abstract][Full Text] [Related]
19. Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion. Fang F; Sun S; Wang L; Guan JL; Giovannini M; Zhu Y; Liu F J Bone Miner Res; 2015 Jul; 30(7):1195-205. PubMed ID: 25639352 [TBL] [Abstract][Full Text] [Related]